Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.
Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
By
Calli McMurray
30 August 2023 | 6 min read
Explore more from The Transmitter
Should we use the computational or the network approach to analyze functional brain-imaging data—why not both?
Emerging methods make it possible to combine the two tactics from opposite ends of the analytic spectrum, enabling scientists to have their cake and eat it too.
Should we use the computational or the network approach to analyze functional brain-imaging data—why not both?
Emerging methods make it possible to combine the two tactics from opposite ends of the analytic spectrum, enabling scientists to have their cake and eat it too.
By
Mac Shine
13 May 2024 | 7 min read
Visual perception improves in the blink of an eye
Blinking—long considered a problem the brain must overcome to produce seamless vision—may actually be more of a feature than a bug, new research suggests.
Visual perception improves in the blink of an eye
Blinking—long considered a problem the brain must overcome to produce seamless vision—may actually be more of a feature than a bug, new research suggests.
By
Angie Voyles Askham
10 May 2024 | 5 min read
The Transmitter Launch: Industry internships, ‘Next Generation Leaders,’ and more
Working at a biotechnology or artificial-intelligence company is no longer an “alternative career” for researchers with a doctorate in neuroscience—plus jobs, training and funding updates for May.
The Transmitter Launch: Industry internships, ‘Next Generation Leaders,’ and more
Working at a biotechnology or artificial-intelligence company is no longer an “alternative career” for researchers with a doctorate in neuroscience—plus jobs, training and funding updates for May.
By
Elissa Welle
10 May 2024 | 4 min read